Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits

MLA

Alaa M. Ali, et al. “Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits.” Antibiotics, vol. 11, no. 11, Nov. 2022, p. 1556. EBSCOhost, https://doi.org/10.3390/antibiotics11111556.

APA

Alaa M. Ali, Harriet J. Hill, Gehad E. Elkhouly, Marwa Reda Bakkar, Nermeen R. Raya, Zania Stamataki, & Yasmin Abo-zeid. (2022). Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits. Antibiotics, 11(11), 1556. https://doi.org/10.3390/antibiotics11111556

Chicago

Alaa M. Ali, Harriet J. Hill, Gehad E. Elkhouly, Marwa Reda Bakkar, Nermeen R. Raya, Zania Stamataki, and Yasmin Abo-zeid. 2022. “Rhamnolipid Nano-Micelles Inhibit SARS-CoV-2 Infection and Have No Dermal or Eye Toxic Effects in Rabbits.” Antibiotics 11 (11): 1556. doi:10.3390/antibiotics11111556.